TLIS (Talis Biomedical) FCF Margin %: 0.00% (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TLIS Talis Biomedical Corp TLIS
28 GF Score
Price $2.84
View Full Analysis

What is Talis Biomedical FCF Margin %?

Talis Biomedical TLIS 28 FCF Margin % is 0.00% as of Jun. 2024. GuruFocus rates TLIS with a GF Score™ of 28/100.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Talis Biomedical's Free Cash Flow for the three months ended in Jun. 2024 was $-11.33 Mil. Talis Biomedical's Revenue for the three months ended in Jun. 2024 was $0.00 Mil. Therefore, Talis Biomedical's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

As of today, Talis Biomedical's current FCF Yield % is 0.00%.

The historical rank and industry rank for Talis Biomedical's FCF Margin % or its related term are showing as below:

TLIS' s FCF Margin % Range Over the Past 10 Years
Min: -13411.67   Med: 0   Max: 0
Current: -13411.67

TLIS's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -0.57 vs TLIS: -13411.67

Talis Biomedical FCF Margin % Related Terms

Talis Biomedical FCF Margin % Historical Data

* Premium members only.

The historical data trend for Talis Biomedical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Talis Biomedical FCF Margin % Chart

Talis Biomedical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 -2,786.17 -13,040.29

Talis Biomedical Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -30,747.92 -14,755.26 -7,459.60 -8,804.11 0.00

TLIS vs BJDX, BBLG, VTAK: FCF Margin % Comparison

For the Medical Devices subindustry, Talis Biomedical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Talis Biomedical FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Talis Biomedical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Talis Biomedical's FCF Margin % falls into.


TLIS
28GF Score
Talis Biomedical Corp TLIS
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Talis Biomedical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Talis Biomedical's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-53.726/0.412
=-13,040.29 %

Talis Biomedical's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-11.33/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Talis Biomedical (TLIS) has a FCF Margin % of 0.00% as of Jun. 2024. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Talis Biomedical and its competitors.
Is Talis Biomedical's FCF Margin % too high?
Talis Biomedical's current FCF Margin % is 0.00%. Overall, Talis Biomedical has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Talis Biomedical's FCF Margin % compare to BJDX and BBLG?
Talis Biomedical's FCF Margin % of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Talis Biomedical and its competitors. Talis Biomedical's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Talis Biomedical stock overvalued right now?
Talis Biomedical (TLIS) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Talis Biomedical's overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Talis Biomedical (TLIS), the current FCF Margin % is 0.00% as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Talis Biomedical Business Description

Address 1375 West Fulton Market, Suite 700, Chicago, IL, USA, 60607
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.
28GF Score

Get the complete analysis for TLIS

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.84
Price